<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04782817</url>
  </required_header>
  <id_info>
    <org_study_id>181117</org_study_id>
    <nct_id>NCT04782817</nct_id>
  </id_info>
  <brief_title>Reducing Reintubation Risk in High-Risk Cardiac Surgery Patients With High-Flow Nasal Cannula</brief_title>
  <official_title>Reducing Reintubation Risk in High-Risk Cardiac Surgery Patients With High-Flow Nasal Cannula</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare reintubation rates and outcomes of patients treated&#xD;
      with high-flow nasal canula oxygen therapy (HFNC) and patients treated with provider choice&#xD;
      of standard care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      HFNC may be employed as a strategy to facilitate early extubation and prevent reintubation of&#xD;
      patients following cardiac surgery. HFNC is routinely employed by providers in the&#xD;
      cardiovascular intensive care unit and is selectively employed in patients who are judged by&#xD;
      the provider to be high-risk, along with other therapies: bi-level positive airway pressure,&#xD;
      non-rebreather masks, among others. Currently, no high-quality clinical data exist to&#xD;
      demonstrate that HFNC may decrease the risk of reintubation in this critically-ill adult&#xD;
      population.&#xD;
&#xD;
      To guide a future, larger, multicenter randomized controlled pragmatic clinical trial, a&#xD;
      pilot study in a single, high-volume cardiovascular intensive care unit will be performed.&#xD;
      The prospective, randomized, pragmatic pilot clinical trial will compare HFNC to provider&#xD;
      choice of standard care in these high-risk patients.&#xD;
&#xD;
      Randomization will occur at the time that the patient is deemed ready for extubation by the&#xD;
      attending physician in the cardiovascular intensive care unit. Through randomization,&#xD;
      patients will be assigned one of two physician order sets in the electronic medical record&#xD;
      system: standard order set with or without recommendation for the use of HFNC. Reintubation&#xD;
      and outcome data will be collected until patient discharge.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2021</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reintubation within 48 hours of extubation</measure>
    <time_frame>48 hours</time_frame>
    <description>Reintubation within 48 hours of initial extubation after cardiac surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reintubation within 72 hours of extubation</measure>
    <time_frame>72 hours</time_frame>
    <description>Reintubation within 72 hours of initial extubation after cardiac surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reintubation after cardiac surgery</measure>
    <time_frame>hospital discharge (usually 14 days)</time_frame>
    <description>Reintubation at any time during hospitalization after cardiac surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital mortality</measure>
    <time_frame>hospital discharge (usually 14 days)</time_frame>
    <description>In-hospital mortality during hospitalization after cardiac surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">3192</enrollment>
  <condition>Intubation</condition>
  <condition>Cardiovascular Surgical Procedure</condition>
  <arm_group>
    <arm_group_label>High Flow Nasal Canula Oxygen Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be assigned post extubation physician order set which recommends the administration of oxygen therapy via HFNC. HFNC is a heated and humidified system that allows prescribed fraction of inspired oxygen (FIO2) levels to be delivered at very high flow rates.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Provider Choice Standard Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants be assigned standard provider choice of standard care therapy physician order set.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Recommendation for high flow nasal cannula oxygen therapy order set</intervention_name>
    <description>Participants will be assigned post extubation physician order set which recommends the administration of oxygen therapy via HFNC. HFNC is a heated and humidified system that allows prescribed fraction of inspired oxygen (FIO2) levels to be delivered at very high flow rates.</description>
    <arm_group_label>High Flow Nasal Canula Oxygen Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Provider choice standard care order set</intervention_name>
    <description>Participants will receive order set with provider choice of standard care therapy.</description>
    <arm_group_label>Provider Choice Standard Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults aged 18 and over treated in the Vanderbilt Cardiovascular Intensive Care Unit&#xD;
             following cardiac surgery (defined as surgery on the heart or thoracic aorta)&#xD;
&#xD;
          -  Intubated at the time of arrival in the Cardiovascular Intensive Care Unit&#xD;
&#xD;
          -  Extubated to occur at some point following arrival in the Cardiovascular Intensive&#xD;
             Care Unit with an order to extubate the patient by a treating provider.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Does not meet inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert E Freundlich, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robert E Freundlich, MD</last_name>
    <phone>(615)936-6608</phone>
    <email>robert.e.freundlich@vumc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gail Mayo</last_name>
    <phone>(615)936-1705</phone>
    <email>gail.mayo@vumc.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert E Freundlich, MD</last_name>
      <phone>615-936-6608</phone>
      <email>robert.e.freundlich@vumc.org</email>
    </contact>
    <contact_backup>
      <last_name>Gail Mayo, RN</last_name>
      <phone>(615)936-1705</phone>
      <email>gail.mayo@vumc.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Khandelwal N, Dale CR, Benkeser DC, Joffe AM, Yanez ND 3rd, Treggiari MM. Variation in tracheal reintubations among patients undergoing cardiac surgery across Washington state hospitals. J Cardiothorac Vasc Anesth. 2015;29(3):551-9. doi: 10.1053/j.jvca.2014.11.009. Epub 2014 Nov 11.</citation>
    <PMID>25802193</PMID>
  </reference>
  <reference>
    <citation>Freundlich RE, Maile MD, Hajjar MM, Habib JR, Jewell ES, Schwann T, Habib RH, Engoren M. Years of Life Lost After Complications of Coronary Artery Bypass Operations. Ann Thorac Surg. 2017 Jun;103(6):1893-1899. doi: 10.1016/j.athoracsur.2016.09.048. Epub 2016 Dec 6.</citation>
    <PMID>27938887</PMID>
  </reference>
  <reference>
    <citation>Dorsa AG, Rossi AI, Thierer J, Lupia√±ez B, Vrancic JM, Vaccarino GN, Piccinini F, Raich H, Bonazzi SV, Benzadon M, Navia DO. Immediate extubation after off-pump coronary artery bypass graft surgery in 1,196 consecutive patients: feasibility, safety and predictors of when not to attempt it. J Cardiothorac Vasc Anesth. 2011 Jun;25(3):431-6. doi: 10.1053/j.jvca.2010.08.013. Epub 2010 Oct 29.</citation>
    <PMID>21036063</PMID>
  </reference>
  <reference>
    <citation>Chan JL, Miller JG, Murphy M, Greenberg A, Iraola M, Horvath KA. A Multidisciplinary Protocol-Driven Approach to Improve Extubation Times After Cardiac Surgery. Ann Thorac Surg. 2018 Jun;105(6):1684-1690. doi: 10.1016/j.athoracsur.2018.02.008. Epub 2018 Mar 9.</citation>
    <PMID>29530778</PMID>
  </reference>
  <reference>
    <citation>Roca O, Hern√°ndez G, D√≠az-Lobato S, Carratal√° JM, Guti√©rrez RM, Masclans JR; Spanish Multidisciplinary Group of High Flow Supportive Therapy in Adults (HiSpaFlow). Current evidence for the effectiveness of heated and humidified high flow nasal cannula supportive therapy in adult patients with respiratory failure. Crit Care. 2016 Apr 28;20(1):109. doi: 10.1186/s13054-016-1263-z. Review.</citation>
    <PMID>27121707</PMID>
  </reference>
  <reference>
    <citation>Markovitz GH, Colthurst J, Storer TW, Cooper CB. Effective inspired oxygen concentration measured via transtracheal and oral gas analysis. Respir Care. 2010 Apr;55(4):453-9.</citation>
    <PMID>20406513</PMID>
  </reference>
  <reference>
    <citation>Bazuaye EA, Stone TN, Corris PA, Gibson GJ. Variability of inspired oxygen concentration with nasal cannulas. Thorax. 1992 Aug;47(8):609-11.</citation>
    <PMID>1412117</PMID>
  </reference>
  <reference>
    <citation>St√©phan F, Barrucand B, Petit P, R√©zaiguia-Delclaux S, M√©dard A, Delannoy B, Cosserant B, Flicoteaux G, Imbert A, Pilorge C, B√©rard L; BiPOP Study Group. High-Flow Nasal Oxygen vs Noninvasive Positive Airway Pressure in Hypoxemic Patients After Cardiothoracic Surgery: A Randomized Clinical Trial. JAMA. 2015 Jun 16;313(23):2331-9. doi: 10.1001/jama.2015.5213.</citation>
    <PMID>25980660</PMID>
  </reference>
  <reference>
    <citation>Masip J, Peacock WF, Price S, Cullen L, Martin-Sanchez FJ, Seferovic P, Maisel AS, Miro O, Filippatos G, Vrints C, Christ M, Cowie M, Platz E, McMurray J, DiSomma S, Zeymer U, Bueno H, Gale CP, Lettino M, Tavares M, Ruschitzka F, Mebazaa A, Harjola VP, Mueller C; Acute Heart Failure Study Group of the Acute Cardiovascular Care Association and the Committee on Acute Heart Failure of the Heart Failure Association of the European Society of Cardiology. Indications and practical approach to non-invasive ventilation in acute heart failure. Eur Heart J. 2018 Jan 1;39(1):17-25. doi: 10.1093/eurheartj/ehx580. Review.</citation>
    <PMID>29186485</PMID>
  </reference>
  <reference>
    <citation>Corley A, Caruana LR, Barnett AG, Tronstad O, Fraser JF. Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. Br J Anaesth. 2011 Dec;107(6):998-1004. doi: 10.1093/bja/aer265. Epub 2011 Sep 9.</citation>
    <PMID>21908497</PMID>
  </reference>
  <reference>
    <citation>Parke R, McGuinness S, Eccleston M. Nasal high-flow therapy delivers low level positive airway pressure. Br J Anaesth. 2009 Dec;103(6):886-90. doi: 10.1093/bja/aep280. Epub 2009 Oct 20.</citation>
    <PMID>19846404</PMID>
  </reference>
  <reference>
    <citation>Zhu Y, Yin H, Zhang R, Wei J. High-flow nasal cannula oxygen therapy vs conventional oxygen therapy in cardiac surgical patients: A meta-analysis. J Crit Care. 2017 Apr;38:123-128. doi: 10.1016/j.jcrc.2016.10.027. Epub 2016 Nov 9. Review.</citation>
    <PMID>27886577</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>March 1, 2021</study_first_submitted>
  <study_first_submitted_qc>March 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 4, 2021</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Robert Freundlich</investigator_full_name>
    <investigator_title>Assistant Professor of Anesthesiology and Biomedical Informatics</investigator_title>
  </responsible_party>
  <keyword>High-flow nasal cannula oxygen therapy</keyword>
  <keyword>Reintubation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

